ArticleBioengineered2021

miR-543 impairs breast cancer cell phenotypes by targeting and suppressing ubiquitin-conjugating enzyme E2T (UBE2T).

Li Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.